Adolescent Weight Management Study

Protocol #1:Behavioral Therapy + Placebo or Sibutramine Clinical Trial

Official title: Behavioral & Pharmacologic Therapy of Adolescent Obesity

Status Completed

Clinical Trial Summary

Protocol #1:The goals of this study was to examine whether increased weight loss in obese adolescent is induced when the weight loss medication sibutramine is added to a family-based, behavioral weight control program.

Protocol #2: This study aims to improve the behavioral treatment of obesity during adolescence. A behavioral program using regular foods will be compared to a behavioral program using a structured meal plan (a portion-controlled approach with liquid-meal replacements [nutritional supplements]). This structured approach may be better for the promotion of weight loss compared to a diet of regular foods.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Protocol #1:Behavioral Therapy + Placebo or Sibutramine
• Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food

• NCT number: NCT00212173
• Study type: Interventional
• Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Status: Completed
• Phase: N/A
• Completion date: August 2007